{"count": 2, "results": [{"_id": "39549271", "pmid": 39549271, "title": "Effective therapy of simvastatin compound ointment in LSS variants-induced palmoplantar keratoderma.", "journal": "Br J Dermatol", "authors": ["Wang Y", "Zhao A", "Huang H", "Zhai Y", "Liu Y", "Yang Y", "Pan C", "Cao Q", "He W", "Zeng Q", "Yan Q", "Li M", "Li M"], "date": "2024-11-16T00:00:00Z", "doi": "10.1093/bjd/ljae451", "meta_date_publication": "2024 Nov 16", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50279.168, "text_hl": "Effective therapy of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ compound ointment in @DISEASE_Laurin_Sandrow_syndrome @DISEASE_MESH:C535689 @@@LSS@@@ variants-induced @<m>DISEASE_Keratoderma_Palmoplantar</m> @DISEASE_MESH:D007645 @@@palmoplantar keratoderma@@@.", "citations": {"NLM": "Wang Y, Zhao A, Huang H, Zhai Y, Liu Y, Yang Y, Pan C, Cao Q, He W, Zeng Q, Yan Q, Li M, Li M. Effective therapy of simvastatin compound ointment in LSS variants-induced palmoplantar keratoderma. Br J Dermatol. 2024 Nov 16;():. PMID: 39549271", "BibTeX": "@article{39549271, title={Effective therapy of simvastatin compound ointment in LSS variants-induced palmoplantar keratoderma.}, author={Wang Y and Zhao A and Huang H and Zhai Y and Liu Y and Yang Y and Pan C and Cao Q and He W and Zeng Q and Yan Q and Li M and Li M}, journal={Br J Dermatol}}"}}, {"_id": "35429339", "pmid": 35429339, "title": "Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation.", "journal": "Australas J Dermatol", "authors": ["Sharma S", "Dayal S", "Aggarwal K", "Gowda V M V", "Kaur R"], "date": "2022-05-01T00:00:00Z", "doi": "10.1111/ajd.13835", "meta_date_publication": "2022 May", "meta_volume": "63", "meta_issue": "2", "meta_pages": "e145-e149", "score": 50267.08, "text_hl": "On genetic analysis, a heterozygous @GENE_KRT6A @GENE_3853 @@@KRT6A@@@ gene missense mutation (@VARIANT_c.1381G>A_KRT6A_human @VARIANT_tmVar:c|SUB|G|1381|A;HGVS:c.1381G>A;VariantGroup:0;CorrespondingGene:3853;RS#:267607468;CorrespondingSpecies:9606;CA#:217327 @@@c.1381G > A@@@, @VARIANT_c.1381G>A_KRT6A_human @VARIANT_tmVar:p|SUB|E|461|K;HGVS:p.E461K;VariantGroup:0;CorrespondingGene:3853;RS#:267607468;CorrespondingSpecies:9606;CA#:217327 @@@p.Glu461Lys@@@ in exon 7) was identified by next-generation sequencing technology, consistent with @DISEASE_Pachyonychia_Congenita @DISEASE_MESH:D053549 @@@pachyonychia congenita 6a@@@. Oral @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 40 mg was started once daily, and after 16 weeks of therapy, excellent improvement was noted in @<m>DISEASE_Keratoderma_Palmoplantar</m> @DISEASE_MESH:D007645 @@@palmoplantar keratoderma@@@ and @DISEASE_Pain @DISEASE_MESH:D010146 @@@plantar pain@@@. ", "citations": {"NLM": "Sharma S, Dayal S, Aggarwal K, Gowda V M V, Kaur R. Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation. Australas J Dermatol. 2022 May;63(2):e145-e149. PMID: 35429339", "BibTeX": "@article{35429339, title={Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation.}, author={Sharma S and Dayal S and Aggarwal K and Gowda V M V and Kaur R}, journal={Australas J Dermatol}, volume={63}, number={2}, pages={e145-e149}}"}}]}